Logo FIGO 2018 | World Congress of Gynecology and Obstetrics
#FIGO2018 #EveryWomanMatters

Company: NESTLE
Room: 201 (A+B) - Raymond Keller
Symposia Title: Preventive Aspects During Pregnancy and Lactation: Is There a Role for Nutritional Interventions?
Speakers: Nutritional Interventions to Reduce the Risk of Gestational Diabetes Mellitus
Dr. Enrique Reyes | Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, México
Lactational Mastitis: Is There a Role for Probiotics?
Dr. Jose Antonio Hurtado | Neonatal Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
Chair person: Prof. Chittaranjan N. Purandare - President FIGO, Dean Indian College Of Obstetrics and Gynaecology

Company: Bayer – YAZ FLEX
Room: 203 (A+B) - Howard Taylor
Yaz® Flex: Flexible Regimen a new concept of of contraception
Chairman Doctor Cesar Fernandes

13:00 - 13:05 - Welcome and Agenda - Dr. Cesar Fernandes
13:05 - 13:25 - The powerful impact of flexible regimen on women's lives - Dr. Johannes Bitzer
13:25 - 13:45 - Yaz® Flex: A revolution contraception - Dr. Rogério Bonassi
13:45 - 13:55 - Q&A - All
13:55 - 14:00 - Wrap up and closure - Dr. Cesar Fernandes

Company: DEKA
Room: 201C  - Alfonso Álvarez Bravo
Stefano Salvatore
Dept of Obstetrics and Gynecology, San Raffaele Hospital, Milan - Italy


Company: Ferring
Room: 201 (A+B) - Raymond Keller
Title: Every woman matters: Challenging PPH prevention in 2018
Chairs: Gian Carlo Di Renzo (Italy), Eduardo Fonseca (Brazil)

13:15 - Introduction - Eduardo Fonseca (Brazil)
13:15–13:35 - PPH – The need for further research - Sabaratnam / Arulkumaran (UK)
13:35–13:55 - CHAMPION – The largest PPH prevention study - Zahida Qureshi (Kenya)
13:55–14:15 - IMox – Comparative clinical trial in the UK setting - Tim Draycott (UK)
14:15 - Close - Gian Carlo Di Renzo (Italy)

Company: Tonederm
Room: 203 (A+B) - Howard Taylor
Invasive and non-invasive treatment: the importance of radiofrequency with transcutaneous temperature control in the treatment of the menopausal urogenital syndrome and the vaginal laxity syndrome.
Dra. Isabel Berardinelli
Dra. Magda Furlanetto
Cristiano Paganin
Company: Natural Cycles Fishawack
Room: 205  - Roberto Caldeyro-Barcia

Exploring the Role of Digital Fertility Awareness Based Methods of Contraception
13:15-13:35 - ‘The Unmet Need for More Contraceptive Choice’ Prof Johannes Bitzer,
University of Basel, Switzerland.
13:35-13:55 - ‘Utilising algorithms to optimise clinical care’ Prof Juan Acuna, Florida
International University, USA.
13:55-14:15 - ‘The evidence base for evaluation of Digital Fertility Awareness Based
Methods of Contraception’ Prof Kristina Gemzell-Danielsson, Karolinska Institutet,
14:15-14:30 - Q&A
Company: Roche
201C  - Alfonso Álvarez Bravo
Title: “Personalized reproductive medicine: the role of Anti-Müllerian Hormone”
Moderator: Dr Alvaro Petracco (Clinica Fertilitat, Porto Alegre, Brazil)
The value of AMH from infertility assessment to treatment individualization 
Dr Gustavo Maciel (Universidade de Sao Paulo (USP), Brazil)
New horizons in ovarian stimulation: AMH-based dosing of follitropin delta
Dr Ernesto Bosch (IVI-RMA Valencia, Spain)

Company: ELMECO
Room: 201 (A+B) - Raymond Keller
Hormonal Implants in gynecology and endocrinology.
Elsimar Metzker Coutinho
Company: Bayer – MIRENA
Room: 203 (A+B) - Howard Taylor
Challenging the status quo: how to increase LARCs utilization rates
Chairman Dr. Agnaldo Silva

13:00 - 13:05 - Welcome and Agenda - Dr. Agnaldo Silva
13:05 - 13:25 - EU guidelines and experience - Dr. Kristina Gemzell
13:25 - 13:45 - US guidelines and experience - Dr. Anita Nelson
13:45 - 13:55 - Q&A - All
13:55 - 14:00 - Wrap up and closure - Dr. Agnaldo Silva

Company: MSD
Room: 205  - Roberto Caldeyro-Barcia
HPV vaccination: where we are and where we want to go?

01:00 - 01:10 HPV vaccination: LATAM current status .
01:10 - 01:30 Opportunities in HPV disease prevention: gender-neutral vaccination and mid-adult women. Luisa Villa, PhD
01:30 - 01:50 Real-World Effectiveness of 4vHPV Vaccination Programs. Edson Moreira, MD, PhD
01:50 - 02:00 Q&A
Company: Vifor pharma
Room: 207 - José Pinotti
Blood loss and the iron need in women: can we do more?
Introduction: Ilza Monteiro (co-chair)
Iron deficiency: a missed opportunity
Rodolfo Cançado (co-chair)
Peri-partum bleeding – an update on treatment approaches to optimize outcomes
Irene Hösli
LATAM consensus – a step by step guide on improving women’s health
Pablo Carpintero

Company: Kedrion
Room: 210 - Giuseppe Tesauro
50 Years of Anti D prophylaxis: Accomplishments and Challenges
Chairpersons: G C Di Renzo, G H Visser

13:00 - 13:10 G C Di Renzo Introduction and video
13:10 - 13.30 G H Visser Global burden of Rh disease: how far are we away from eradication?
13:30 – 13:50 E Fonseca Rh disease in Brazil nowadays
13:50 – 14:10 D Farine Rh disease in Canada : first country to adopt the nationwide prevention
14:10 – 14:30 a "Women Delivery" speaker (TBA) The role of women in preventing HDFN

Company: Roche
Room: 201C - Alfonso Álvarez Bravo
How is cfDNA testing best implemented? Should we limit testing to singleton pregnancies?
Maria Del Mar GIL, MD, PhD
Hospital Universitario de Torrejón - Madrid, Spain
 How do different cfDNA tests compare? Should we expand the scope of cfDNA testing beyond common trisomies?
Gian Carlo DI RENZO, MD, PhD
University Hospital of Perugia -Perugia, Italy


Company: GSK
Room: 201 (A+B) - Raymond Keller
Title: Share protection through Maternal Immunization: your role is key in newborn pertussis prevention
Program (65 mins presentations & 25 mins Q&A) - speakers to be confirmed:

13:00-13:05 Introduction and welcome
13:05-13:25 Pertussis in neonates: why there is a need for Maternal Immunization?
13:25-13:45 The UK experience in Maternal Immunization implementation
13:45-14:05 Best practices on how to discuss Maternal Immunization with pregnant patients
14:05-14:30 Concluding remarks and round-table discussion, with questions from the audience

Company: Bayer – CONSUMER
Room: 203 (A+B) - Howard Taylor
NATELE®: Micronutrients in pregnancy: the foundation for development and lifelong health
Chairman Dr. Eduardo Fonseca

13:00 - 13:05 - Welcome and Agenda - Dr. Eduardo Fonseca
13:05 - 13:20 - Nutricionals status of women of child bearing age in Brazil/LATAM - Dr. Eduardo Fonseca
13:20 - 13:35 - Critical role of micronutrients during pregnancy and lactation - Prof. Berthold Koletzko
13:35 - 13:50 - Micronutrients deficiency and epigenetic signatures in the placenta - Prof. Irene Cetin
13:50 - 14:00 - Q&A, Wrap up and Summary - Dr. Eduardo Fonseca

Company: SANOFI
Room: 205  - Roberto Caldeyro-Barcia
O manejo do TEV na mulher: principais guidelines e condutas internacionais
Dr. André Luiz Malavasi
VTE management in women: the main guidelines and international conducts
Dr. André Luiz Malavasi

Company: OM Pharma AS (Vifor pharma group)
Room: 207  - José Pinotti
Filling the gap between Guidelines and clinical practice in UTI management

13:15 - Welcome - Chairman: Prof. Jorge Haddad
13:20 - Disease burden and importance of proper diagnosis and identification of patients at risk for recurrent UTIs - Dr. Jakhonghir Alidjanov
13:35 - Guidelines in urological infections: overview on prophylaxis -Prof. Suzanne Geerlings
13:50 - How to achieve an improved management of UTI in clinical practice: a LATAM consensus - Prof. Jorge Haddad
14:05 - Discussion - All
14:15 - End of the symposium - All

















Scroll Up